Emcure Pharmaceuticals IPO Details
Overview
Emcure Pharmaceuticals is set to launch its IPO on July 3, 2024, which will close on July 5, 2024. The company aims to raise approximately ₹[.] crores, which includes a fresh issue of ₹800 crores and an offer for sale of up to 11,428,839 equity shares at ₹5 each. The allocation for retail investors is 35%, for Qualified Institutional Buyers (QIB) is 50%, and for High Net-worth Individuals (HNI) is 15%.
Key Dates
- IPO Open Date: July 3, 2024
- IPO Close Date: July 5, 2024
- Allotment Date: July 8, 2024
- Refunds Date: July 9, 2024
- Credit to Demat Accounts: July 9, 2024
- Listing Date: July 10, 2024
Price and Market Lot
- IPO Price Band: ₹960 to ₹1008 per share
- Face Value: ₹10 per equity share
- Discount for Employees: ₹90 per share
Market Lot
- Minimum: 14 shares (₹14,112)
- Maximum: 196 shares (₹197,568)
Emcure Pharmaceuticals Financial Report
Year | Revenue (₹ in Crores) | Expense (₹ in Crores) | PAT (₹ in Crores) |
---|---|---|---|
2022 | 5918.86 | 4946.31 | 702.56 |
2023 | 6031.72 | 5278.36 | 561.85 |
2024 | 6715.24 | 5978.08 | 527.58 |
HNI Market Lot
- Small HNI: 15 lots (210 shares, ₹211,680)
- Big HNI: 71 lots (994 shares, ₹10,01,952)
Company Financials (₹ in Crores)
Company Overview
Emcure Pharmaceuticals is an Indian pharmaceutical company engaged in developing, manufacturing, and globally marketing a broad range of products. The company has a strong presence in over 70 countries, including India, Europe, and Canada. Emcure is the 13th largest pharmaceutical company in India by domestic sales and leads in the gynecology and HIV antivirals sectors.
Objectives of the Issue
- Repayment or prepayment of certain borrowings.
- General corporate purposes.
Peer Group
- Dr. Reddy’s Laboratories Limited
- Cipla Limited
- Alkem Laboratories Limited
- Torrent Pharmaceuticals Limited
- Mankind Pharma Limited
- Abbott India Limited
- J.B. Chemicals & Pharmaceuticals Limited
Promoters
- Satish Mehta
- Sunil Mehta
Lead Managers (Merchant Bankers)
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
Registrar
Link Intime India Private Ltd
- Phone: +91-22-4918 6270
- Email: emcure.ipo@linkintime.co.in
- Website: [Link Intime](https://linkintime.co.in/)
Company Contact
Emcure Pharmaceuticals Limited
- Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune -411 057
- Phone: +91 20 3507 0033
- Email: investors@emcure.co.in
- Website: [Emcure Pharmaceuticals](https://www.emcure.com/)